Fig. 3: Individual antibody concentrations predicted by the model, estimated on Phase I data, for a random sample of participants from the six clinical studies. | npj Vaccines

Fig. 3: Individual antibody concentrations predicted by the model, estimated on Phase I data, for a random sample of participants from the six clinical studies.

From: Prediction of long-term humoral response induced by the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola

Fig. 3: Individual antibody concentrations predicted by the model, estimated on Phase I data, for a random sample of participants from the six clinical studies.

Each subplot represents the individual antibody dynamics (in log10 ELISA units/mL) from 7 days after the 2nd vaccination. For each participant, the vertical dashed line represents the time limit (individual peak of dynamics) between the predictions (on the left) and the forecasts (short-term in blue and long-term in orange). Plain dots correspond to observations used to evaluate individual parameters while circles are observations not used in parameter estimation. Shaded areas correspond to 95% individual prediction intervals (accounting for the uncertainty on the individual parameter estimation and the measurement error) and the solid lines correspond to the prediction of the model.

Back to article page